These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3882111)

  • 1. Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer.
    Friedlander ML; Russell P; Taylor IW; Tattersall MH
    Br J Cancer; 1985 Mar; 51(3):319-33. PubMed ID: 3882111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of DNA ploidy and expression of tumour-associated antigens on human oral carcinomas xenografted in nude mice.
    Damodaran A; Gangal SG; Pichan D; Amin K; Fakih AR; Jambhekar N; Rao R; Chiplunkar SV
    Oral Oncol; 1997 Nov; 33(6):402-7. PubMed ID: 9509123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular DNA content--a stable feature in epithelial ovarian cancer.
    Friedlander ML; Taylor IW; Russell P; Tattersall MH
    Br J Cancer; 1984 Feb; 49(2):173-9. PubMed ID: 6696818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and pharmacological characterisation of three models of human ovarian carcinoma established in nude mice: use of the CA125 tumour marker to predict antitumour activity.
    Burbridge MF; Kraus-Berthier L; Naze M; Pierre A; Atassi G; Guilbaud N
    Int J Oncol; 1999 Dec; 15(6):1155-62. PubMed ID: 10568822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
    Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
    Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice.
    Ward BG; Wallace K; Shepherd JH; Balkwill FR
    Cancer Res; 1987 May; 47(10):2662-7. PubMed ID: 3567897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice.
    Alagoz T; Buller RE; Anderson B; Terrell KL; Squatrito RC; Niemann TH; Tatman DJ; Jebson P
    Cancer; 1995 May; 75(9):2313-22. PubMed ID: 7536123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human ovarian tumours heterotransplanted to "nude" mice.
    Kullander S; Rausing A; Tropé C
    Acta Obstet Gynecol Scand; 1978; 57(2):149-59. PubMed ID: 636856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations.
    Ricci F; Bizzaro F; Cesca M; Guffanti F; Ganzinelli M; Decio A; Ghilardi C; Perego P; Fruscio R; Buda A; Milani R; Ostano P; Chiorino G; Bani MR; Damia G; Giavazzi R
    Cancer Res; 2014 Dec; 74(23):6980-90. PubMed ID: 25304260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tumour necrosis factor on human tumour xenografts in nude mice.
    Balkwill FR; Ward BG; Fiers W
    Ciba Found Symp; 1987; 131():154-69. PubMed ID: 3131073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy.
    Massazza G; Tomasoni A; Lucchini V; Allavena P; Erba E; Colombo N; Mantovani A; D'Incalci M; Mangioni C; Giavazzi R
    Int J Cancer; 1989 Sep; 44(3):494-500. PubMed ID: 2777413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of newly established human ovarian carcinoma cell line--special reference of the effects of cis-platinum on cellular proliferation and release of CA125.
    Ishiwata I; Ishiwata C; Soma M; Nozawa S; Ishikawa H
    Gynecol Oncol; 1987 Mar; 26(3):340-54. PubMed ID: 2435620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of DNA content in human ovarian cancers.
    Erba E; Ubezio P; Pepe S; Vaghi M; Marsoni S; Torri W; Mangioni C; Landoni F; D'Incalci M
    Br J Cancer; 1989 Jul; 60(1):45-50. PubMed ID: 2803914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal DNMT1 mediates cisplatin resistance in ovarian cancer.
    Cao YL; Zhuang T; Xing BH; Li N; Li Q
    Cell Biochem Funct; 2017 Aug; 35(6):296-303. PubMed ID: 28791708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth kinetics of human lung tumours in nude mice.
    Mattern J; Haag D; Wayss K; Volm M
    Exp Cell Biol; 1981; 49(1):34-40. PubMed ID: 7450107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrotisation in nude mice xenografts by the reversible protein synthesis inhibitor zilascorb(2H).
    Pettersen EO; Larsen RO; Dornish JM; Børretzen B; Juul ME; Aastveit TE; Nesland JM; Rofstad EK; Oftebro R
    Br J Cancer; 1993 Apr; 67(4):650-6. PubMed ID: 8471421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
    Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
    Taetle R; Rosen F; Abramson I; Venditti J; Howell S
    Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts.
    Houba PH; Boven E; Erkelens CA; Leenders RG; Scheeren JW; Pinedo HM; Haisma HJ
    Br J Cancer; 1998 Dec; 78(12):1600-6. PubMed ID: 9862570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a human cell line from an ovarian mixed Müllerian tumor (carcinosarcoma).
    van Haaften-Day C; Russell P; Carr S; Wright L
    In Vitro Cell Dev Biol; 1988 Oct; 24(10):965-71. PubMed ID: 2903136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.